TREACE MEDICAL CONCEPT

Treace Medical Concepts Reports First Quarter 2025 Financial Results

08 May 2025 16:05:01 By Nasdaq GlobeNewswire

Treace to Report First Quarter 2025 Financial Results on May 8, 2025

24 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

Treace Announces Upcoming Board Chair Transition

07 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

28 Mar 2025 14:00:00 By Nasdaq GlobeNewswire

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

25 Mar 2025 16:15:00 By Nasdaq GlobeNewswire

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results

27 Feb 2025 16:05:01 By Nasdaq GlobeNewswire

Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

06 Feb 2025 16:15:00 By Nasdaq GlobeNewswire

Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant

30 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue

13 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference

02 Jan 2025 16:15:00 By Nasdaq GlobeNewswire

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure

30 Dec 2024 08:15:00 By Nasdaq GlobeNewswire

Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant

16 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities

04 Dec 2024 16:15:00 By Nasdaq GlobeNewswire

Treace Appoints Guy Guglielmino as Chief Commercial Officer

02 Dec 2024 16:15:00 By Nasdaq GlobeNewswire

Treace Announces Participation at Stifel 2024 Healthcare Conference

18 Nov 2024 16:46:28 By Nasdaq GlobeNewswire

Treace Medical Concepts Reports Third Quarter 2024 Financial Results

05 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Treace Announces Participation in the UBS Global Healthcare Conference

04 Nov 2024 17:29:50 By Nasdaq GlobeNewswire

Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings

04 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure

04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Treace to Report Third Quarter 2024 Financial Results on November 5, 2024

22 Oct 2024 16:30:00 By Nasdaq GlobeNewswire